mRNA Cancer Vaccines and Therapeutics Market - Global Outlook and Forecast 2021-2027

March 2021 | 90 pages | ID: MA4611D509A5EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of mRNA Cancer Vaccines and Therapeutics in Global, including the following market information:

Global mRNA Cancer Vaccines and Therapeutics Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global mRNA Cancer Vaccines and Therapeutics market was valued at 117.7 million in 2020 and is projected to reach US$ 229.5 million by 2027, at a CAGR of 18.2% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the mRNA Cancer Vaccines and Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global mRNA Cancer Vaccines and Therapeutics Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Type, 2020 (%)

• Adeno Carcinomas
• Mucinous Carcinomas
• Adenosquamous Carcinomas

China mRNA Cancer Vaccines and Therapeutics Market, By Application, 2016-2021, 2022-2027 ($ millions)

China mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Application, 2020 (%)

• Infectious Disease
• Cancer
• Others

Global mRNA Cancer Vaccines and Therapeutics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global mRNA Cancer Vaccines and Therapeutics Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total mRNA Cancer Vaccines and Therapeutics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total mRNA Cancer Vaccines and Therapeutics Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Moderna Therapeutics
• CureVac
• Translate Bio
• BioNTech
• Sangamo Therapeutics
• Argos Therapeutics
• In-Cell-Art
• eTheRNA
• Ethris
• Tiba Biotechnology

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 mRNA Cancer Vaccines and Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global mRNA Cancer Vaccines and Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MRNA CANCER VACCINES AND THERAPEUTICS OVERALL MARKET SIZE

2.1 Global mRNA Cancer Vaccines and Therapeutics Market Size: 2021 VS 2027
2.2 Global mRNA Cancer Vaccines and Therapeutics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top mRNA Cancer Vaccines and Therapeutics Players in Global Market
3.2 Top Global mRNA Cancer Vaccines and Therapeutics Companies Ranked by Revenue
3.3 Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 mRNA Cancer Vaccines and Therapeutics Companies in Global Market, by Revenue in 2020
3.5 Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Market Size Markets, 2021 & 2027
  4.1.2 Adeno Carcinomas
  4.1.3 Mucinous Carcinomas
  4.1.4 Adenosquamous Carcinomas
4.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2021
  4.2.2 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2022-2027
  4.2.3 By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2021 & 2027
  5.1.2 Infectious Disease
  5.1.3 Cancer
  5.1.4 Others
5.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2021
  5.2.2 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2022-2027
  5.2.3 By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Market Size, 2021 & 2027
6.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2021
  6.2.2 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue, 2022-2027
  6.2.3 By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
  6.3.2 US mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.3.3 Canada mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.3.4 Mexico mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
  6.4.2 Germany mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.4.3 France mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.4.4 U.K. mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.4.5 Italy mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.4.6 Russia mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.4.7 Nordic Countries mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.4.8 Benelux mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
  6.5.2 China mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.5.3 Japan mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.5.4 South Korea mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.5.5 Southeast Asia mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.5.6 India mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
  6.6.2 Brazil mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.6.3 Argentina mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027
  6.7.2 Turkey mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.7.3 Israel mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.7.4 Saudi Arabia mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027
  6.7.5 UAE mRNA Cancer Vaccines and Therapeutics Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Moderna Therapeutics
  7.1.1 Moderna Therapeutics Corporate Summary
  7.1.2 Moderna Therapeutics Business Overview
  7.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.1.4 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.1.5 Moderna Therapeutics Key News
7.2 CureVac
  7.2.1 CureVac Corporate Summary
  7.2.2 CureVac Business Overview
  7.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.2.4 CureVac mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.2.5 CureVac Key News
7.3 Translate Bio
  7.3.1 Translate Bio Corporate Summary
  7.3.2 Translate Bio Business Overview
  7.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.3.4 Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.3.5 Translate Bio Key News
7.4 BioNTech
  7.4.1 BioNTech Corporate Summary
  7.4.2 BioNTech Business Overview
  7.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.4.4 BioNTech mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.4.5 BioNTech Key News
7.5 Sangamo Therapeutics
  7.5.1 Sangamo Therapeutics Corporate Summary
  7.5.2 Sangamo Therapeutics Business Overview
  7.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.5.4 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.5.5 Sangamo Therapeutics Key News
7.6 Argos Therapeutics
  7.6.1 Argos Therapeutics Corporate Summary
  7.6.2 Argos Therapeutics Business Overview
  7.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.6.4 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.6.5 Argos Therapeutics Key News
7.7 In-Cell-Art
  7.7.1 In-Cell-Art Corporate Summary
  7.7.2 In-Cell-Art Business Overview
  7.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.4.4 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.7.5 In-Cell-Art Key News
7.8 eTheRNA
  7.8.1 eTheRNA Corporate Summary
  7.8.2 eTheRNA Business Overview
  7.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.8.4 eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.8.5 eTheRNA Key News
7.9 Ethris
  7.9.1 Ethris Corporate Summary
  7.9.2 Ethris Business Overview
  7.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.9.4 Ethris mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.9.5 Ethris Key News
7.10 Tiba Biotechnology
  7.10.1 Tiba Biotechnology Corporate Summary
  7.10.2 Tiba Biotechnology Business Overview
  7.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Major Product Offerings
  7.10.4 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue in Global (2016-2021)
  7.10.5 Tiba Biotechnology Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. mRNA Cancer Vaccines and Therapeutics Market Opportunities & Trends in Global Market
Table 2. mRNA Cancer Vaccines and Therapeutics Market Drivers in Global Market
Table 3. mRNA Cancer Vaccines and Therapeutics Market Restraints in Global Market
Table 4. Key Players of mRNA Cancer Vaccines and Therapeutics in Global Market
Table 5. Top mRNA Cancer Vaccines and Therapeutics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global mRNA Cancer Vaccines and Therapeutics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global mRNA Cancer Vaccines and Therapeutics Revenue Share by Companies, 2016-2021
Table 8. Global Companies mRNA Cancer Vaccines and Therapeutics Product Type
Table 9. List of Global Tier 1 mRNA Cancer Vaccines and Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 mRNA Cancer Vaccines and Therapeutics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - mRNA Cancer Vaccines and Therapeutics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2022-2027
Table 30. Moderna Therapeutics Corporate Summary
Table 31. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 32. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 33. CureVac Corporate Summary
Table 34. CureVac mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 35. CureVac mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 36. Translate Bio Corporate Summary
Table 37. Translate Bio mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 38. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 39. BioNTech Corporate Summary
Table 40. BioNTech mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 41. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 42. Sangamo Therapeutics Corporate Summary
Table 43. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 44. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 45. Argos Therapeutics Corporate Summary
Table 46. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 47. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 48. In-Cell-Art Corporate Summary
Table 49. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 50. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 51. eTheRNA Corporate Summary
Table 52. eTheRNA mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 53. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 54. Ethris Corporate Summary
Table 55. Ethris mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 56. Ethris mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)
Table 57. Tiba Biotechnology Corporate Summary
Table 58. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Offerings
Table 59. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. mRNA Cancer Vaccines and Therapeutics Segment by Type
Figure 2. mRNA Cancer Vaccines and Therapeutics Segment by Application
Figure 3. Global mRNA Cancer Vaccines and Therapeutics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global mRNA Cancer Vaccines and Therapeutics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global mRNA Cancer Vaccines and Therapeutics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by mRNA Cancer Vaccines and Therapeutics Revenue in 2020
Figure 8. By Type - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 9. By Application - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 10. By Region - Global mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 11. By Country - North America mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 12. US mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 16. Germany mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 17. France mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 24. China mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 28. India mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 30. Brazil mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa mRNA Cancer Vaccines and Therapeutics Revenue Market Share, 2016-2027
Figure 33. Turkey mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE mRNA Cancer Vaccines and Therapeutics Revenue, (US$, Mn), 2016-2027
Figure 37. Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. CureVac mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Translate Bio mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. BioNTech mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. In-Cell-Art mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. eTheRNA mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Ethris mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 46. Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)